Research Library
749 papers · 149 analysis articles
Research Analysis
Curated deep-dives into the latest peptide research
Investigating Tirzepatide's Impact on Eye Health in People with Obesity
Peptide Therapy in Focus: New Study Investigates Amylin's Role in Post-Traumatic Headache
Rimegepant Moves to Phase 3 for Chronic Migraine Prevention
New Study Investigates Tirzepatide's Impact on Gastric Emptying in Type 1 Diabetes Patients
Secukinumab Retention Rates Studied in Psoriasis Patients with or Without GLP-1 RA Co-Therapy
Investigational Tirzepatide Dose Study Completed for Type 2 Diabetes and Obesity Patients
Papers Database
Effect of thymosin α1 on Immune response and organ function in acute aortic dissection surgery: PANDA II trial protocol.
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Comparison of tirzepatide and dulaglutide on major adverse cardiovascular events in participants with type 2 diabetes and atherosclerotic cardiovascular disease: SURPASS-CVOT design and baseline characteristics.
Effect of Semaglutide on Physical Function, Body Composition, and Biomarkers of Aging in Older Adults With Overweight and Insulin Resistance: Protocol for an Open-Labeled Randomized Controlled Trial.
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial.
Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial.
A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.
Phase I/II Multicenter Trial of a Novel Therapeutic Cancer Vaccine, HepaVac-101, for Hepatocellular Carcinoma.
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity.
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial.
Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma.
[The efficacy of semax in the tretament of patients at different stages of ischemic stroke].
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
Growth hormone response to hexarelin, growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen in prepubertal and early pubertal short children.